Search companies
EN
Login
Register
Home
J-Pharma Co., Ltd.
J-Pharma Co., Ltd.
520A
・
Growth Market
・
Pharmaceuticals
Follow Company
Official website
J-Pharma Co., Ltd.
520A
・
Growth Market
・
Pharmaceuticals
Official website
Follow Company
Company info
Management's Perspective
Reports
J-Pharma Co., Ltd.
520A
Company info
Management's Perspective
Reports
Follow Company
J-Pharma Co., Ltd.
520A
Follow Company
Company info
Management's Perspective
Reports
Financials & metrics
Company overview
Segments
Business risks
Governance & ESG
Company data
Disclosures
Financials & metrics
Company overview
Segments
Business risks
Governance & ESG
Company data
Disclosures
Recent Disclosures
Date
Type
Title
2026-10-30
Other
AAMED「難病・希少疾病治療グローバル研究開発支援事業」に係る補助金の交付決定および補助事業開始のお知らせ
2026-10-30
Other
Notice of Grant approval and Commencement of the Grant-Funded Project under AMED’s GRiT Program
2026-10-19
Other
Envalith Co., Ltd. to Initiate Research Coverage of J-Pharma
2026-10-19
Other
株式会社エンヴァリスによる当社株式のリサーチ・カバレッジ開始のお知らせ
2026-10-15
Other
J-Pharma Establishes a Business Operations Departmen
2026-10-15
Other
事業推進部新設のお知らせ - 開発品の事業提携等を着実に推進する組織体制を強化 -
2026-10-14
Other
J-Pharma Decides on Policy to Expand Part A of the Global Phase III Beacon-BTC Study of Nanvuranlat to Japan and South Korea
2026-10-14
Other
ナンブランラトの国際共同第3相試験「Beacon-BTC」Part Aの日本・韓国への展開方針を決定
2026-10-09
Other
J-Pharma Holds Investigator Meeting to Prepare for Expansion of the Global Phase III Beacon-BTC Study of Nanvuranlat to Japan
2026-10-09
Other
ナンブランラトの国際共同第3相試験「Beacon-BTC」の日本展開に向けたInvestigator Meetingを開催
Disclaimer